Global Hormonal Contraceptive Market by Method (Combined Oral Contraceptives, Oral Contraceptives Implanted Contraceptives, Injected Contraceptives, Intrauterine, others), Hormones, End-Users, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

  • Publish Date: Mar, 2019
  • Report ID: 375980
  • Category: Pharmaceutical
  • Pages: 0
$4,700

The global hormonal contraceptive market is expected to reach from USD 19.31 Billion in 2017 to USD 31.07 Billion by 2025 at a CAGR of 5.80% from 2018 to 2025. Increasing awareness about reproductive and sexual health worldwide and an increase in women population around the world are driving the growth of the market.

Market Overview:

Hormonal contraceptives are used as a birth control method. These pills act on the endocrine system. These are used to prevent ovulation and in turn pregnancy. However, they do not protect against HIV or other sexually transmitted infections. Two types of hormonal contraceptives are available in the market progestin-only contraceptive and combination hormonal contraceptive. Increasing focus towards family planning and the need for preventing teenage pregnancies are fuelling the market.

Report Description:

  • The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global hormonal contraceptive market is analyzed by value (USD Billion).
  • The study delivers a comprehensive analysis of the global hormonal contraceptive market by the method, hormones, end user and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used to recognize the competitive scenario in the global hormonal contraceptive market. This report incorporates the industry analysis which is focused on providing an extensive view of the global hormonal contraceptive market.
  • The study also includes attractiveness analysis method, hormones, end user and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the global hormonal contraceptive market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Increasing awareness regarding contraception methods in developing countries
  • Rising adoption of hormonal contraception for birth control
  • Growing female population worldwide
  • Urbanization and increased consciousness about contraception

Restraints:

  • Side effects associated with the use of hormonal contraceptives

Opportunities:

  • High demand for low-cost contraceptive practices in home care settings

Challenges:

  • Lack of awareness in emerging economies

Global Hormonal Contraceptive Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global hormonal contraceptive market is segmented by the method, hormones, and end user.

  • The method segment is classified into combined oral, oral contraceptive, implanted, injected, intrauterine, transdermal patch, and vaginal ring contraceptives. The oral contraceptive segment accounted for the largest market share and was valued around USD 6.948 billion in 2017. Easy mode of administration, a wide range of availability and high awareness about pills are driving the growth of the segment.
  • Hormones segment is divided into androgens, estrogens, progestogens, gonadotropins, antiandrogens, and others. Increase in prevalence of PCOS, fewer side effects and effective results than progestin contraceptives makes other hormones preferred choice.
  • End-user segment is classified into hospitals, homecare, gynecology centers, clinics, and ambulatory surgical centers.

 

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region captured the largest share of the global hormonal contraceptive market and was valued around USD 8.87 billion in 2017 whereas Asia Pacific is expected to witness the highest CAGR in the forecast period.

  • North America region is expected to dominate the market owing to high income, the strong presence of major market players, higher awareness about sexual health and a large number of unintended pregnancies.
  • Asia Pacific is projected to be fastest growing region in the forecast period due to Large fertile population, the introduction of new female contraception devices and rise in investment by are the major factors supplementing the growth of the region.

Global Hormonal Contraceptive Market Competitive Analysis:

Major players operating in the global hormonal contraceptive market are Teva Pharmaceutical, Amgen, Sun Pharmaceutical, Bayer Healthcare, Piramal Healthcare, Cipla Limited, Pfizer, Inc., Glenmark Pharmaceuticals, Novartis AG, Lupin Pharmaceuticals, Reckitt Benckiser Plc, HLL Lifecare Limited, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life Care and others. Extensive product portfolio and expansion strategies by major players are contributing to the growth of the sector. For instance, in March 2017, TEVA launched generics of Minastrin 24 Fe-ethinyl estradiol & norethindrone acetate tablets and ferrous fumarate tablets. These are used as an oral contraceptive in the U.S.

This study forecasts revenue growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global hormonal contraceptive market by below-mentioned segments:

Global Hormonal Contraceptive Market, By Method:

  • Combined Oral Contraceptives
  • Oral Contraceptives
  • Implanted Contraceptives
  • Injected Contraceptives
  • Intrauterine
  • Trasdermal Patch
  • Vaginal Ring

Global Hormonal Contraceptive Market, By Hormones:

  • Androgens
  • Estrogens
  • Progestogens
  • Gonadotropins
  • Antiandrogens
  • Others

Global Hormonal Contraceptive Market, By End-Users:

  • Hospitals
  • Homecare
  • Gynecology Centers
  • Clinics
  • Ambulatory Surgical Centers

Global Hormonal Contraceptive Market, By Regions:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market attractiveness analysis by method
        4.3.2. Market attractiveness analysis by hormones
        4.3.3. Market attractiveness analysis by end user
        4.3.4. Market attractiveness analysis by region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. Increasing Awareness Regarding Contraception Methods in Developing Countries
        5.2.2. Rising Adoption of Hormonal Contraception for Birth Control
        5.2.3. Growing Female Population Worldwide
        5.2.4. Urbanization and Increased Consciousness about Contraception
   5.3. Restraints
        5.3.1. Side Effects Associated with Use of Hormonal Contraceptives
   5.4. Opportunities
        5.4.1. High Demand For Low Cost Contraceptive Practices In Home Care Settings
   5.5. Challenges
        5.5.1. Lack of Awareness In Emerging Economies

6. Global Hormonal Contraceptive Market Analysis and Forecast, By Method
   6.1. Segment Overview
   6.2. Combined Oral Contraceptives
   6.3. Oral Contraceptives
   6.4. Implanted Contraceptives
   6.5. Injected Contraceptives
   6.6. Intrauterine
   6.7. Trasdermal Patch
   6.8. Vaginal Ring

7. Global Hormonal Contraceptive Market Analysis and Forecast, By Hormones
   7.1. Segment Overview
   7.2. Androgens
   7.3. Estrogens
   7.4. Progestogens
   7.5. Gonadotropins
   7.6. Antiandrogens
   7.7. Others

8. Global Hormonal Contraceptive Market Analysis and Forecast, By End User
   8.1. Segment Overview
   8.2. Hospitals
   8.3. Homecare
   8.4. Gynecology Centers
   8.5. Clinics
   8.6. Ambulatory Surgical Centers

9. Global Hormonal Contraceptive Market Analysis and Forecast, By Regional Analysis
   9.1. Segment Overview
   9.2. North America
        9.2.1. U.S.
        9.2.2. Canada
        9.2.3. Mexico
   9.3. Europe
        9.3.1. Germany
        9.3.2. France
        9.3.3. Sweden
        9.3.4. Netherlands
        9.3.5. U.K.
        9.3.6. Italy
        9.3.7. Spain
        9.3.8. Turkey
        9.3.9. Switzerland
        9.3.10. Belgium
        9.3.11. Rest of Europe
   9.4. Asia-Pacific
        9.4.1. Japan
        9.4.2. China
        9.4.3. India
        9.4.4. South Korea
        9.4.5. Australia
        9.4.6. Singapore
        9.4.7. Malaysia
        9.4.8. Thailand
        9.4.9. Indonesia
        9.4.10. Philippines
        9.4.11. Rest of Asia-Pacific
   9.5. South America
        9.5.1. Brazil
        9.5.2. Argentina
        9.5.3. Colombia
        9.5.4. Rest of South America
   9.6. Middle East and Africa
        9.6.1. Saudi Arabia
        9.6.2. UAE
        9.6.3. Egypt
        9.6.4. Nigeria
        9.6.5. South Africa
        9.6.6. Rest of  Middle East and Africa

10. Global Hormonal Contraceptive Market-Competitive Landscape
   10.1. Overview
   10.2. Market Share of Key Players in the Hormonal Contraceptive Market
        10.2.1. Global Company Market Share
        10.2.2. North America Company Market Share
        10.2.3. Europe Company Market Share
        10.2.4. APAC Company Market Share
   10.3. Competitive Situations and Trends
        10.3.1. Product Launches and Developments
        10.3.2. Partnerships, Collaborations, and Agreements
        10.3.3. Mergers & Acquisitions
        10.3.4. Expansions

11. Company Profiles
   11.1. Teva Pharmaceutical
        11.1.1. Business Overview
        11.1.2. Company Snapshot
        11.1.3. Company Market Share Analysis
        11.1.4. Company Product Portfolio
        11.1.5. Recent Developments
        11.1.6. SWOT Analysis
   11.2. Amgen
        11.2.1. Business Overview
        11.2.2. Company Snapshot
        11.2.3. Company Market Share Analysis
        11.2.4. Company Product Portfolio
        11.2.5. Recent Developments
        11.2.6. SWOT Analysis
   11.3. Sun Pharmaceutical
        11.3.1. Business Overview
        11.3.2. Company Snapshot
        11.3.3. Company Market Share Analysis
        11.3.4. Company Product Portfolio
        11.3.5. Recent Developments
        11.3.6. SWOT Analysis
   11.4. Bayer Healthcare
        11.4.1. Business Overview
        11.4.2. Company Snapshot
        11.4.3. Company Market Share Analysis
        11.4.4. Company Product Portfolio
        11.4.5. Recent Developments
        11.4.6. SWOT Analysis
   11.5. Piramal Healthcare
        11.5.1. Business Overview
        11.5.2. Company Snapshot
        11.5.3. Company Market Share Analysis
        11.5.4. Company Product Portfolio
        11.5.5. Recent Developments
        11.5.6. SWOT Analysis
   11.6. Cipla Limited
        11.6.1. Business Overview
        11.6.2. Company Snapshot
        11.6.3. Company Market Share Analysis
        11.6.4. Company Product Portfolio
        11.6.5. Recent Developments
        11.6.6. SWOT Analysis
   11.7. Pfizer, Inc.
        11.7.1. Business Overview
        11.7.2. Company Snapshot
        11.7.3. Company Market Share Analysis
        11.7.4. Company Product Portfolio
        11.7.5. Recent Developments
        11.7.6. SWOT Analysis
   11.8. Glenmark Pharmaceuticals
        11.8.1. Business Overview
        11.8.2. Company Snapshot
        11.8.3. Company Market Share Analysis
        11.8.4. Company Product Portfolio
        11.8.5. Recent Developments
        11.8.6. SWOT Analysis
   11.9. Novartis AG
        11.9.1. Business Overview
        11.9.2. Company Snapshot
        11.9.3. Company Market Share Analysis
        11.9.4. Company Product Portfolio
        11.9.5. Recent Developments
        11.9.6. SWOT Analysis
   11.10. Lupin Pharmaceuticals
        11.10.1. Business Overview
        11.10.2. Company Snapshot
        11.10.3. Company Market Share Analysis
        11.10.4. Company Product Portfolio
        11.10.5. Recent Developments
        11.10.6. SWOT Analysis
   11.11. Reckitt Benckiser Plc
        11.11.1. Business Overview
        11.11.2. Company Snapshot
        11.11.3. Company Market Share Analysis
        11.11.4. Company Product Portfolio
        11.11.5. Recent Developments
        11.11.6. SWOT Analysis
   11.12. HLL Lifecare Limited
        11.12.1. Business Overview
        11.12.2. Company Snapshot
        11.12.3. Company Market Share Analysis
        11.12.4. Company Product Portfolio
        11.12.5. Recent Developments
        11.12.6. SWOT Analysis
   11.13. Boehringer Ingelheim GmbH
        11.13.1. Business Overview
        11.13.2. Company Snapshot
        11.13.3. Company Market Share Analysis
        11.13.4. Company Product Portfolio
        11.13.5. Recent Developments
        11.13.6. SWOT Analysis
   11.14. Watson Pharmaceuticals, Inc
        11.14.1. Business Overview
        11.14.2. Company Snapshot
        11.14.3. Company Market Share Analysis
        11.14.4. Company Product Portfolio
        11.14.5. Recent Developments
        11.14.6. SWOT Analysis
   11.15. V-Care Pharma Pvt. Ltd.
        11.15.1. Business Overview
        11.15.2. Company Snapshot
        11.15.3. Company Market Share Analysis
        11.15.4. Company Product Portfolio
        11.15.5. Recent Developments
        11.15.6. SWOT Analysis


List of Table
1. Global Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
2. Global Combined Oral Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
3. Global Oral Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
4. Global Implanted Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
5. Global Injected Contraceptives Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
6. Global Intrauterine Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
7. Global Trasdermal Patch Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
8. Global Vaginal Ring Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
9. Global Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
10. Global Androgens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
11. Global Estrogens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
12. Global Progestogens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
13. Global Gonadotropins Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
14. Global Neurosurgeries Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
15. Global Antiandrogens Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
16. Global Gynecological Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
17. Global Hormonal Contraceptive Market, By End-Users, 2015–2025 (USD Billion)
18. Global Hospitals Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
19. Global Homecare Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
20. Global Gynecology Centers Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
21. Global Clinics Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
22. Global Ambulatory Surgical Centers Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion)
23. Global Hormonal Contraceptive Market, By Region, 2015–2025 (USD Billion) 
24. North America Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
25. North America Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
26. North America Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
27. U.S. Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
28. U.S. Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
29. U.S. Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
30. Canada Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
31. Canada Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
32. Canada Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
33. Mexico Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
34. Mexico Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
35. Mexico Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
36. Europe Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
37. Europe Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
38. Europe Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
39. Germany Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
40. Germany Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
41. Germany Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
42. France Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
43. France Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
44. France Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
45. Sweden Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
46. Sweden Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
47. Sweden Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
48. Netherlands Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
49. Netherlands Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
50. Netherlands Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
51. U.K. Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
52. U.K. Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
53. U.K. Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
54. Italy Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
55. Italy Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
56. Italy Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
57. Spain Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
58. Spain Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
59. Spain Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
60. Turkey Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
61. Turkey Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
62. Turkey Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
63. Switzerland Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
64. Switzerland Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
65. Switzerland Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
66. Belgium Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
67. Belgium Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
68. Belgium Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion)
69. Asia Pacific Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
70. Asia Pacific Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
71. Asia Pacific Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
72. Japan Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
73. Japan Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
74. Japan Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
75. China Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
76. China Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
77. China Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
78. India Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
79. India Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
80. India Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
81. South Korea Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
82. South Korea Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
83. South Korea Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
84. Australia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
85. Australia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
86. Australia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
87. Singapore Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
88. Singapore Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
89. Singapore Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
90. Malaysia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
91. Malaysia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
92. Malaysia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
93. Thailand Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
94. Thailand Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
95. Thailand Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
96. Indonesia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
97. Indonesia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
98. Indonesia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
99. Philippines Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
100. Philippines Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
101. Philippines Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
102. South America Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
103. South America Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
104. South America Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
105. Brazil Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
106. Brazil Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
107. Brazil Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
108. Argentina Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
109. Argentina Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
110. Argentina Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
111. Colombia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
112. Colombia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
113. Colombia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
114. Middle East and Africa Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
115. Middle East and Africa Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
116. Middle East and Africa Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
117. Saudi Arabia Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
118. Saudi Arabia Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
119. Saudi Arabia Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
120. UAE Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
121. UAE Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
122. Egypt Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
123. Egypt Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
124. Egypt Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
125. Nigeria Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
126. Nigeria Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion) 
127. Nigeria Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 
128. South Africa Hormonal Contraceptive Market, By Method, 2015–2025 (USD Billion) 
129. South Africa Hormonal Contraceptive Market, By Hormones, 2015–2025 (USD Billion)
130. South Africa Hormonal Contraceptive Market, By End User, 2015–2025 (USD Billion) 

List of Figures 
1. Global Hormonal Contraceptive Market Segmentation
2. Hormonal Contraceptive Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis 
7. Value Chain Analysis 
8. Global Hormonal Contraceptive Market attractiveness analysis by Method
9. Global Hormonal Contraceptive Market attractiveness analysis by Hormones
10. Global Hormonal Contraceptive Market attractiveness analysis by End User
11. Global Hormonal Contraceptive Market attractiveness analysis by Region
12. Global Hormonal Contraceptive Market: Dynamics
13. Global Hormonal Contraceptive Market Share by Method (2017 & 2025)
14. Global Hormonal Contraceptive Market Share by Hormones (2017 & 2025)
15. Global Hormonal Contraceptive Market Share by End User (2017 & 2025)
16. Global Hormonal Contraceptive Market Share by Regions (2017 & 2025)
17. Global Hormonal Contraceptive Market Share by Company (2018)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.